Rapport Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Rapport Therapeutics 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About RAPP

Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. 

CEO
Abraham N. Ceesay
CEOAbraham N. Ceesay
Employees
69
Employees69
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
2022
Founded2022
Employees
69
Employees69

RAPP Key Statistics

Market cap
1.36B
Market cap1.36B
Price-Earnings ratio
-10.19
Price-Earnings ratio-10.19
Dividend yield
Dividend yield
Average volume
369.81K
Average volume369.81K
High today
$28.59
High today$28.59
Low today
$26.82
Low today$26.82
Open price
$27.46
Open price$27.46
Volume
167.46K
Volume167.46K
52 Week high
$42.27
52 Week high$42.27
52 Week low
$6.43
52 Week low$6.43

Stock Snapshot

The current Rapport Therapeutics(RAPP) stock price is $27.44, with a market capitalization of 1.36B. The stock trades at a price-to-earnings (P/E) ratio of -10.19.

As of 2026-02-04, Rapport Therapeutics(RAPP) stock has fluctuated between $26.82 and $28.59. The current price stands at $27.44, placing the stock +2.3% above today's low and -4.0% off the high.

The Rapport Therapeutics(RAPP)'s current trading volume is 167.46K, compared to an average daily volume of 369.81K.

In the last year, Rapport Therapeutics(RAPP) shares hit a 52-week high of $42.27 and a 52-week low of $6.43.

In the last year, Rapport Therapeutics(RAPP) shares hit a 52-week high of $42.27 and a 52-week low of $6.43.

Analyst ratings

100%

of 10 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own RAPP. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.